HomeProductsFAQ BlogWhatsApp Us
Home › Blog › Vitiligo Treatment Options: Creams, Phototherapy & Depigmentation
Patient Guide

Vitiligo Treatment Options Explained: Creams, Phototherapy & Depigmentation

Updated August 5, 202610 min readGulfDermaCare

Table of Contents

  1. Understanding Vitiligo — A Starting Point
  2. Treatment Approach 1: Topical Therapies
  3. Treatment Approach 2: Phototherapy
  4. Treatment Approach 3: Surgical Treatments
  5. Treatment Approach 4: Permanent Depigmentation
  6. Choosing the Right Treatment
  7. Emerging Treatments (2026)
📋 Content Review Process: Medical claims on this page are cross-checked against FDA prescribing information, DermNet NZ, and the American Academy of Dermatology. See our Medical References for sources.

Understanding Vitiligo — A Starting Point

Vitiligo is an autoimmune condition in which the immune system mistakenly attacks melanocytes — the skin cells responsible for producing pigment — creating characteristic white patches that can appear anywhere on the body, affecting an estimated 1-2% of the global population according to the Global Vitiligo Foundation, with notably higher prevalence (2-3%) across GCC countries. Treatment falls into two broad categories: repigmentation approaches (topical steroids, calcineurin inhibitors, NB-UVB phototherapy), which attempt to restore color to affected patches and work best for limited vitiligo; and depigmentation therapy using monobenzone cream, reserved for extensive vitiligo (50%+ body surface area) where repigmentation is unlikely to achieve a uniform cosmetic result. The right choice depends on how much of the body is affected, how the condition has responded to prior treatment, and the patient's own goals — a decision best made together with a dermatologist rather than in isolation.

Treatment Approach 1: Topical Therapies

Topical Corticosteroids

The most common first-line treatment for limited vitiligo. Steroids suppress the autoimmune response attacking melanocytes, allowing some repigmentation. Best for small, active lesions particularly on the face and trunk.

Topical Calcineurin Inhibitors (Tacrolimus, Pimecrolimus)

Alternative to steroids without the skin-thinning side effect. Particularly useful for facial vitiligo and sensitive skin areas.

Topical JAK Inhibitors (Ruxolitinib)

The newest topical option (FDA-approved 2022). Targets the JAK-STAT inflammatory pathway that drives vitiligo. Ruxolitinib cream 1.5% has shown significant repigmentation in clinical trials.

Treatment Approach 2: Phototherapy

Narrowband UVB (NB-UVB)

Currently the gold standard for widespread vitiligo repigmentation. Specific UV wavelength (311nm) targets remaining melanocytes without the carcinogenic risk of older UV therapies.

PUVA (Psoralen + UVA)

Older phototherapy combining psoralen (oral or topical) with UVA exposure. Less commonly used now due to higher carcinogenic risk compared to NB-UVB.

Excimer Laser/Lamp (308nm)

Targeted UV therapy for small or resistant patches. Can deliver high-dose UV to specific lesions without treating surrounding healthy skin.

Treatment Approach 3: Surgical Treatments

For stable vitiligo (no new patches for 2+ years) that has not responded to medical treatment:

Treatment Approach 4: Permanent Depigmentation

For extensive vitiligo (50%+ body surface) where repigmentation is unlikely to achieve a cosmetically acceptable result, permanent depigmentation removes remaining pigmented skin to create a uniform white appearance.

Agent: Monobenzone cream (FDA-approved) — the only approved agent for this purpose.

📋 GulfDermaCare supplies: Monobenzone cream 20%, 40%, and 60% with delivery to all GCC countries in 3-7 days. WhatsApp: +923174900576

Choosing the Right Treatment

Vitiligo ExtentRecommended First-LineWhen to Consider Depigmentation
Under 10%Topical steroids or calcineurin inhibitorsGenerally not indicated
10–30%NB-UVB phototherapy ± topicalsIf repigmentation fails after 2+ years
30–50%NB-UVB + topicals; consider surgicalIf 50% threshold approaching after failed treatment
50%+NB-UVB (partial) or depigmentationPrimary consideration after patient counselling

Emerging Treatments (2026)

Buy Monobenzone Cream — GulfDermaCare

Iranian Brand (Monozan by Behvazan Pharma) · From $12 · Ships to GCC in 3-7 days

Order on WhatsApp

Frequently Asked Questions

What is the best treatment for vitiligo?
The most appropriate treatment for vitiligo depends heavily on the extent of skin affected and individual patient goals, rather than a single universal answer. For limited vitiligo affecting smaller areas, narrowband UVB phototherapy combined with topical treatments such as corticosteroids or calcineurin inhibitors represents the standard first-line approach, aiming to restore pigment to affected patches. For extensive vitiligo covering fifty percent or more of body surface area, where repigmentation has already been attempted and failed, permanent depigmentation using monobenzone cream becomes a reasonable option to discuss with a dermatologist. The right choice ultimately requires an individualized conversation weighing treatment history, extent of involvement, and personal preference regarding a reversible versus permanent approach.
Can vitiligo be cured?
Vitiligo cannot currently be permanently cured in the sense of restoring the underlying autoimmune process that causes it, though various treatments can meaningfully address its visible effects. Repigmentation therapies, including phototherapy and topical treatments, can restore natural pigment to affected patches with varying degrees of success, though results are often partial and vitiligo may progress or recur over time even after successful treatment. Permanent depigmentation using monobenzone takes a fundamentally different approach: rather than restoring pigment, it creates a stable, uniform skin appearance by removing the remaining pigmented skin to match existing white patches. This represents a management strategy for achieving visual consistency rather than a cure for the underlying condition itself.
Is NB-UVB better than monobenzone for vitiligo?
Narrowband UVB phototherapy and monobenzone serve fundamentally different and essentially opposite purposes in vitiligo treatment, despite both being legitimate dermatological approaches. NB-UVB phototherapy aims to restore natural pigment to white patches by stimulating remaining melanocytes, making it a repigmentation strategy typically used as first-line treatment for limited vitiligo. Monobenzone, in contrast, removes remaining pigmented skin entirely, making it a depigmentation strategy that creates uniform appearance rather than restoring color. Because of this opposite mechanism, NB-UVB is generally the appropriate first-line choice for limited vitiligo, while monobenzone becomes a consideration specifically for extensive vitiligo cases where repigmentation approaches like NB-UVB have already been tried and have not achieved a satisfactory result.
How long does vitiligo treatment take?
The treatment timelines for these two fundamentally different approaches vary considerably and require different levels of ongoing commitment. Repigmentation therapies using narrowband UVB phototherapy typically require a substantial commitment of twelve months or more, with sessions scheduled two to three times per week throughout that entire period, and results often continuing to develop gradually beyond the first year. Monobenzone-based depigmentation, by contrast, generally takes nine to twelve months of consistent twice-daily topical application to achieve complete results, without requiring in-clinic phototherapy sessions. Both approaches demand significant patience and consistency, but their practical time commitment differs meaningfully, phototherapy requires frequent clinic visits, while monobenzone is self-administered at home under periodic dermatologist supervision.
What treatments are available in Saudi Arabia and UAE for vitiligo?
Major hospitals and dermatology clinics across Saudi Arabia and the UAE offer a range of vitiligo treatment options, including narrowband UVB phototherapy sessions, various topical treatments, and referral pathways to specialized dermatology consultants for more complex or extensive cases. These healthcare systems are generally well-equipped to manage repigmentation-focused approaches for patients with limited vitiligo. For patients specifically seeking monobenzone cream for permanent depigmentation of extensive vitiligo, GulfDermaCare provides direct pharmaceutical supply with delivery to Saudi Arabia typically completed within three to six business days, and similar delivery windows across other GCC countries, since this specific product is not always readily available through standard local pharmacy channels in the region.

Related Pages

HomeProducts Benoquin AlternativeMonozan Cream Saudi ArabiaUAE Shipping PolicyContact What Is Monobenzone Cream?Side Effects Guide FAQAll Articles